Literature DB >> 16246061

Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress.

N T Watt1, N M Hooper.   

Abstract

The PrP(C) [cellular isoform of PrP (prion protein)] can undergo a conformational conversion to produce a proteinase-resistant form PrP(Sc) (scrapie isoform of PrP), a step critical for the development of prion disease. Although essential for disease progression, the normal cellular function of PrP(C) remains unknown. Suggestions to date have centred on a protective role against oxidative stress. We have demonstrated that ROS (reactive oxygen species)-mediated beta-cleavage of PrP(C) occurs at the cell surface, can be inhibited following hydroxyl radical quenching and has a prerequisite for the octarepeat region in the N-terminus of the protein. Significantly, two disease-associated mutants of PrP, namely PG14 and A116V (Ala(116)-->Val), were unable to undergo beta-cleavage and this lack of proteolysis was accompanied by functional consequences in cells expressing these mutant proteins. The cells were found to be less viable following exposure to copper and H2O2, had reduced levels of glutathione peroxidase and increased amounts of intracellular oxygen radicals. These results suggest that beta-cleavage of PrP(C) is an initial consequence following exposure to ROS in the extracellular environment contributing to a pathway involved in antioxidant protection of neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246061     DOI: 10.1042/BST20051123

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  14 in total

1.  Cellular prion protein (PrP(C)) and its role in stress responses.

Authors:  Liang Zeng; Wenquan Zou; Gongxian Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Axonal prion protein is required for peripheral myelin maintenance.

Authors:  Juliane Bremer; Frank Baumann; Cinzia Tiberi; Carsten Wessig; Heike Fischer; Petra Schwarz; Andrew D Steele; Klaus V Toyka; Klaus-Armin Nave; Joachim Weis; Adriano Aguzzi
Journal:  Nat Neurosci       Date:  2010-01-24       Impact factor: 24.884

Review 3.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

4.  Fluorimetric analysis of copper transport mechanisms in the b104 neuroblastoma cell model: a contribution from cellular prion protein to copper supplying.

Authors:  Emanuela Urso; Antonia Rizzello; Raffaele Acierno; Maria Giulia Lionetto; Benedetto Salvato; Carlo Storelli; Michele Maffia
Journal:  J Membr Biol       Date:  2009-12-03       Impact factor: 1.843

Review 5.  Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

6.  Effects of shear stresses and antioxidant concentrations on the production of reactive oxygen species in lung cancer cells.

Authors:  Kai-Yin Lo; Yun Zhu; Hsieh-Fu Tsai; Yung-Shin Sun
Journal:  Biomicrofluidics       Date:  2013-11-26       Impact factor: 2.800

7.  Modeling by assembly and molecular dynamics simulations of the low Cu2+ occupancy form of the mammalian prion protein octarepeat region: gaining insight into Cu2+-mediated beta-cleavage.

Authors:  M Jake Pushie; Hans J Vogel
Journal:  Biophys J       Date:  2008-09-12       Impact factor: 4.033

Review 8.  PrP overdrive: does inhibition of α-cleavage contribute to PrP(C) toxicity and prion disease?

Authors:  Alex J McDonald; Glenn L Millhauser
Journal:  Prion       Date:  2014-04-10       Impact factor: 3.931

Review 9.  Cellular aspects of prion replication in vitro.

Authors:  Andrea Grassmann; Hanna Wolf; Julia Hofmann; James Graham; Ina Vorberg
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

10.  Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease.

Authors:  Mauricio Torres; Luis Cartier; José Manuel Matamala; Nancy Hernández; Ute Woehlbier; Claudio Hetz
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.